A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity
Open Access
- 1 May 2013
- journal article
- Vol. 4, S147-S158
Abstract
A variety of techniques for the management of spasticity have been suggested, including positioning, cryotherapy, splinting and casting, biofeedback, electrical stimulation, and medical management by pharmacological agents, Botulinum toxin A (BTA) is now the pharmacological treatment of choice in focal spasticity. BTA by blocking acetylcholine release at neuromuscular junctions accounts for its therapeutic action to relieve spasticity. A computerized search of Pub Med was carried out to find the latest result about efficacy of BTA in management of post stroke spasticity. Among 84 articles were found, frothy of them included in this review and divided to lower and upper extremity. BTA is a treatment choice in reducing tone and managing post stroke spasticity .Keywords
This publication has 53 references indexed in Scilit:
- Spasticity After StrokeAmerican Journal of Physical Medicine & Rehabilitation, 2012
- Evidence to Practice: Botulinum Toxin in the Treatment of Spasticity Post StrokeTopics in Stroke Rehabilitation, 2012
- A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after strokeClinical Rehabilitation, 2012
- Cortical Activation Changes in Patients Suffering from Post‐Stroke Arm Spasticity and Treated with Botulinum Toxin AJournal of Neuroimaging, 2011
- Botulinum toxin type A in post-stroke upper limb spasticityCurrent Medical Research and Opinion, 2010
- Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.2007
- Botulinum toxin in post-stroke patients: stiffness modifications and clinical implicationsJournal of Neurology, 2004
- Spasticity After Stroke2004
- [Spasticity and botulinum toxin in 2003. An update].2003
- [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].1999